Pacira BioSciences (PCRX) Accumulated Expenses (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Accumulated Expenses of $85.0 million for Q1 2026, up 6.1% year-over-year from $80.1 million in Q1 2025, and down 11.13% quarter-over-quarter from $95.6 million in Q4 2025.
Pacira BioSciences (PCRX) Accumulated Expenses (2010 - 2026) Analysis & Trends
Pacira BioSciences' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $85.0 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 6.1% year-over-year to $85.0 million; the TTM figure through Mar 2026 stood at $85.0 million (up 6.1% YoY), while the FY2025 annual figure was $95.6 million, up 19.32% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $85.0 million, down from $95.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $95.6 million in Q4 2025, with the low at $56.2 million in Q2 2023.
- The 5-year median for Accumulated Expenses is $76.4 million (2024), against an average of $74.9 million.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses jumped 74.5% in 2022, then retreated 29.7% in 2023.
- Pacira BioSciences' Accumulated Expenses stood at $89.8 million in 2022, then decreased by 28.45% to $64.2 million in 2023, then gained by 24.72% to $80.1 million in 2024, then advanced by 19.32% to $95.6 million in 2025, then fell by 11.13% to $85.0 million in 2026.
- Business Quant data shows PCRX's Accumulated Expenses at $85.0 million in Q1 2026, $95.6 million in Q4 2025, and $79.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Pacira BioSciences | 945.31 Mn | 694.28 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.50 Mn |
| Mar 31, 2026 | 84.96 Mn |
| Dec 31, 2025 | 95.60 Mn |
| Sep 30, 2025 | 79.64 Mn |
| Jun 30, 2025 | 71.02 Mn |
| Mar 31, 2025 | 80.07 Mn |
| Dec 31, 2024 | 80.12 Mn |
| Sep 30, 2024 | 76.38 Mn |
| Jun 30, 2024 | 64.81 Mn |
| Mar 31, 2024 | 66.82 Mn |
| Dec 31, 2023 | 64.24 Mn |
| Sep 30, 2023 | 59.88 Mn |
| Jun 30, 2023 | 56.22 Mn |
| Mar 31, 2023 | 61.63 Mn |
| Dec 31, 2022 | 89.79 Mn |
| Sep 30, 2022 | 76.36 Mn |
| Jun 30, 2022 | 77.28 Mn |
| Mar 31, 2022 | 87.67 Mn |
| Dec 31, 2021 | 127.56 Mn |
| Sep 30, 2021 | 50.80 Mn |